Veeva：2023年肿瘤学团队应该在EDC中寻找什么（英文版）

Most oncology teams are working feverishly to deliver medicines to patients quickly and safely, yet numerous inefficiencies slow them down. Advances in oncology need to be matched by advances in the clinical systems supporting those trials. Immuno-therapies have advantages over traditional chemotherapy. They are less toxic, can address hard-to-treat cancers, and provide a durable response that in some cases lasts years after treatment ends.1 They are also complicated to study as their efficac